|
|
||||||||
Articles |
-tocopherol-supplemented LDL
Department of Medical Sciences, 2nd Faculty of Medicine, University of Torino, Via Solaroli 17, I-28100 Novara, Italy.
a Author for correspondence. Fax +321 620 421.
Isolated human LDL, used in the native form or supplemented with
-tocopherol (
T), were oxidized with Cu2+,
2,2'-azobis-(2-amidino propane) hydrochloride (AAPH), and
H2O2 plus horseradish peroxidase (HRP). The
oxidation kinetics were measured spectrophotometrically at 234 nm to
follow the formation of conjugated dienes and evaluated as resistance
to oxidation (lag phase, LP) and maximal oxidation rate (propagation
rate, PR). The duration of LP in nonsupplemented LDL was different with
the three prooxidant stimuli (LP, in min: 96 ± 19 for
Cu2+, 28.7 ± 6.7 for HRP, and 67.1 ± 11.2 for
AAPH). No correlation was found between the values obtained with
Cu2+ and AAPH or HRP, but a significant correlation was
found with AAPH and HRP (r = 0.798, P
<0.002). In vitro
T supplementation prolonged the LP and decreased
the PR with all the stimuli. The extent of increase in LP was highly
correlated (r = 0.872, P <0.001 for
Cu2+ and HRP; r = 0.603, P
<0.03 for Cu2+ and AAPH; r = 0.749,
P <0.005 for AAPH and HRP). Although the evaluation of
ex vivo LDL oxidation is dependent on the prooxidant
stimulus, the three prooxidant conditions used detect equally well the
efficiency of
T supplementation in preventing LDL oxidation.
Key Words: indexing terms: free radicals lipid peroxidation
The following articles in journals at HighWire Press have cited this article:
![]() |
M. A. Atkin, A. Gasper, R. Ullegaddi, and H. J. Powers Oxidative Susceptibility of Unfractionated Serum or Plasma: Response to Antioxidants in Vitro and to Antioxidant Supplementation Clin. Chem., November 1, 2005; 51(11): 2138 - 2144. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Palomaki, K. Malminiemi, O. Malminiemi, and T. Solakivi Effects of Lovastatin Therapy on Susceptibility of LDL to Oxidation During {alpha}-Tocopherol Supplementation Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1541 - 1548. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |